Promoting Women's Health: A Gender Specific Smoking Cessation Program for Female Smokers in Hong Kong

What Was Tested

In this not phased trial, researchers set out to test Therapeutic nicotine (patch, non-peptide).

This project aims to publicize quitting among female smokers, and encourage and support those who want to quit by providing face-to-face and/or telephone counseling.

The objectives are to: 1.

Build up a Women Against Tobacco Taskforce (WATT) with woman volunteers from various organizations to promote quitting in female smokers, and to arouse public awareness of the effects of smoking on sexual, reproductive and child health, and other diseases among women. 2.

It had 1 arm (groups): Brief counseling and NRT (experimental).

The registry classes the interventions as drug.

More on the Plan

Phase I: Build up a network and need assessment 1.

This proposed Task Force will focus on promoting smoking cessation among female smokers and arousing the public's awareness of health risks specific to women from smoking. 2.

Need assessment survey and focus group interview of the women volunteers and staff: all volunteers and staff will be invited to participate in a need assessment survey and focus group interview.

The perceived needs identified will be used to design a tailor-made smoking cessation counselor training curriculum for the participants, and they will be asked to indicate their interest and commitment to undertake such training (free of charge), and to help women quit smoking.

Who Took Part

Enrollment: 480 planned participants were the target.

It was open to women only aged from 15 years with no upper age limit.

Healthy volunteers were not accepted; participants needed the condition being studied.

Examples of who could join: Hong Kong female resident aged 18 or above. Able to communicate in Chinese (Cantonese).

The full record lists 3 inclusion and 2 exclusion criteria; among the exclusions: have difficulty to communicate via telephone; having queries irrelevant to tobacco control.

How the Study Was Run

It was run as a single-group and open-label study.

Nothing was hidden in this open-label Therapeutic nicotine (patch, non-peptide) study: the participants and staff both knew the treatment.

Everyone received the same intervention, so there was no separate comparison group inside the trial.

It started in 2006-04-01 with completion listed for 2024-10-01.

It ran at 1 site in China.

Its stated primary purpose is health services research.

What Was Measured

Primary outcome: 7-days point prevalence smoking abstinence at 6-month (time frame: 6-month follow-up).

It also tracked 1 secondary outcome, for example Bio-chemical validated smoking abstinence at 6-,36-,72-month.

What This Means in Plain Language

Put simply, this is a not phased trial of Therapeutic nicotine (patch, non-peptide) in 480 people.

Its status is unknown; no results are posted to the registry yet, so nothing here describes outcomes.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.